🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the safety and preliminary efficacy of an in...
Status
Not Yet Recruiting
Location
the first affiliated hospital of Zhejiang university school of medicine, Hangzhou, Zhejiang 310000
Start Date
2026-05-01
Trial ID
NCT07577986
Treatments Being Tested
This is a single-center, single-arm, open-label, dose-escalation clinical s...
Status
Unknown
Location
the first affiliated hospital of Zhejiang University，school of medicine
Start Date
2024-07-09
Trial ID
NCT06503497
Treatments Being Tested
This is a single-center, single-arm, open-label, dose-escalation clinical s...
Status
Recruiting
Location
The First Affiliated Hospital Zhejiang University School of Medicine
Start Date
2025-06-10
Trial ID
NCT07021534
Treatments Being Tested
Evaluate the clinical safety and feasibility of NKG2D CAR-T administrated b...
Status
Unknown
Location
The Third Affiliated Hospital of Guangzhou Medical University
Start Date
2021-09-13
Trial ID
NCT05248048
Treatments Being Tested
This is a single-center, single-arm, open-label, dose-escalation clinical s...
Status
Unknown
Location
the first affiliated hospital of Zhejiang University，school of medicine
Start Date
2024-06-09
Trial ID
NCT06478459
Treatments Being Tested
This is a single-arm, open-label, multi-center, Phase 1 study to determine ...
Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute
Start Date
2020-09-21
Trial ID
NCT04623944
Treatments Being Tested
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal...
Status
Unknown
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2021-12-10
Trial ID
NCT05213195
Treatments Being Tested
Multiple myeloma (MM) is a malignant disease characterized by the abnormal ...
Status
Unknown
Location
Changzhou Second People's Hospital
Start Date
2024-04-18
Trial ID
NCT06379451
Treatments Being Tested
This trial will explore the maximum tolerated dose of cord blood NKG2D CAR-...
Status
Terminated
Location
Hebei Yanda Lu Daopei Hospital
Start Date
2021-10-13
Trial ID
NCT05247957
Treatments Being Tested
SARS-CoV-2 infection mainly leads to interstitial pneumonia. The patients w...
Status
Unknown
Location
Chongqing Public Health Medical Center
Start Date
2020-02-21
Trial ID
NCT04324996
Treatments Being Tested